Evaluation of destructive effects of exposure to cisplatin during developmental stage: No profound evidence for sex differences in impaired motor and memory performance

International Journal of Neuroscience

Volumn 122, Issue 8, 2012, Pages 439-448

  Shabani, Mohammad ^a   Larizadeh, Mohammad Hassan ^a   Parsania, Shahrnaz ^a   Hajali, Vahid ^a   Shojaei, Ahdiye ^b  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b PAYAME NOOR UNIVERSITY   (Iran)

Author keywords

anticancer; cisplatin; learning; memory; motor function

Indexed keywords

CISPLATIN;

ADOLESCENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CEREBELLUM; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DRUG EXPOSURE; EXPLORATORY BEHAVIOR; FEMALE; GRIP STRENGTH; HIPPOCAMPUS; HISTOPATHOLOGY; LEARNING; MALE; MAZE TEST; MEMORY; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NONHUMAN; OPEN FIELD TEST; RAT; ROTAROD TEST; SEX DIFFERENCE; TASK PERFORMANCE; VELOCITY;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC AGENTS; BODY WEIGHT; BRAIN; CISPLATIN; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FEMALE; HAND STRENGTH; MALE; MAZE LEARNING; MEMORY DISORDERS; MOTOR ACTIVITY; MOVEMENT DISORDERS; NEURONS; PSYCHOMOTOR PERFORMANCE; RATS; ROTAROD PERFORMANCE TEST; SEX CHARACTERISTICS; SPACE PERCEPTION;

EID: 84863864018     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2012.673515     Document Type: Article

References (43)

1. Ahles TA, Saykin AJ. Breast cancer chemotherapy-related cognitive dysfunction. Clin Breast Cancer. 2002;3:84-90.
2. Correa DD, Ahles TA, Neurocognitive changes in cancer survivors. Cancer J. 2008;14(6):396-400.
3. Prestayko AW, D'Aoust JC, Issell BF, Crooke ST. Cisplatin (cis-diamminedichloroplatinum II). Cancer Treat Rev. 1979;6(1):17-39. (Pubitemid 9189580)
4. Screnci D, McKeage MJ. Platinum neurotoxicity: clinical profiles, experimental models and neuroprotective approaches. J Inorg Biochem. 1999;77(1-2):105-110. (Pubitemid 30089089)
5. Sweeney CJ, Zhu J, Sandler AB, Schiller J, Belani CP, Langer C, Krook J, Harrington D, Johnson DH. Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594. Cancer. 2001;92(10):2639-2647.
6. Paksoy M, AE, Sanli A, Eken M, Aydin S, Oktay ZA. The protective effects of intratympanic dexamethasone and vitamin E on cisplatin-induced ototoxicity are demonstrated in rats. Med Oncol. 2011;28(2):615-621.
7. Gallo JM, Laub PB, Rowinsky EK, Grochow LB, Baker SD. Population pharmacokinetic model for topotecan derived from phase I clinical trials. J Clin Oncol., 2000;18(12):2459-2467. (Pubitemid 30415833)
8. Loos WJ, Gelderblom H, Verweij J, van Boven-van Zomeren DM, Nooter K, Stoter G, Sparreboom A. Red blood cells: a neglected compartment in topotecan pharmacokinetic analysis. Anti-Cancer Drugs. 2003;14(3):227-232. (Pubitemid 36418942)
9. Wall AM, Gajjar A, Link A,Mahmoud H, Pui CH, RellingMV. Individualized methotrexate dosing in children with relapsed acute lymphoblastic leukemia. Leukemia. 2000;14(2):221-225. (Pubitemid 30095374)
10. Morris ME, Lee HJ, Predko LM. Gender differences in the membrane transport of endogenous and exogenous compounds. Pharmacol Rev. 2003;55(2):229-240. (Pubitemid 36666047)
11. Mihalick SM. Perinatal exposure to diethylstilbestrol improves olfactory discrimination learning in male and female Swiss-Webster mice. Neurobiol Learn Mem. 2003;80(1):55-62. (Pubitemid 36539438)
12. Argyriou AA, Polychronopoulos P, Koutras A, Xiros N, Petsas T, Argyriou K, Kalofonos HP, Chroni E. Clinical and electrophysiological features of peripheral neuropathy induced by administration of cisplatin plus paclitaxel based chemotherapy. Eur J Cancer Care 2007;16(3):231-237.
13. Yalcin S, NG, Orhan B, Zeybek D, Müftüoǧlu S, Sarer B, Yildirim BA, Cetin E. Protective effect of amifostine against cisplatin-induced motor neuropathy in rat. Med Oncol. 2003;20(2):175-180.
14. Shabani M, Hosseinmardi N, Haghani M, Shaibani V, Janahmadi M. Maternal exposure to the CB1 cannabinoid agonist WIN 55212-2 produces robust changes in motor function and intrinsic electrophysiological properties of cerebellar Purkinje neurones in rat offspring. Neuroscience. 2011;13(172):139-152.
15. Van Wijk N, Rijntjes E, Van De Heijning B. Perinatal and chronic hypothyroidism impair behavioural development in male and female rats. Exp Physiol. 2008;93(11):1199-1209.
16. Frick KM, Stillner ET, Berger-Sweeney J. Mice are not little rats: species differences in a one-day water maze task. Neuroreport. 2000;11(16):3461-3465.
17. Rzeski W, Pruskil S, Macke A, Felderhoff-Mueser U, Reiher AK, Hoerster F, Jansma C, Jarosz B, Stefovska V, Bittigau P, Ikonomidou C. Anticancer agents are potent neurotoxins in vitro and in vivo. Ann Neurol. 2004;56(3):351-360. (Pubitemid 39166554)
18. Hill A, Bergin P, Hanning F, Thompson P, Findlay M, Damianovich D, McKeage MJ. Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability. BMC Cancer. 2010;10(1):451.
19. BottoneMG, Soldani C, Veneroni P, Avella D, Pisu M, Bernocchi G. Cell proliferation, apoptosis and mitochondrial damage in rat B50 neuronal cells after cisplatin treatment. Cell Proliferat. 2008;41(3):506-520. (Pubitemid 351692946)
20. Pisu MB, Roda E, Guioli S, Avella D, Bottone MG, Bernocchi G. Proliferation and migration of granule cells in the developing rat cerebellum: cisplatin effects. Anat Rec A Discov Mol Cell Evol Biol. 2005;287(2):1226-1235. (Pubitemid 43010433)
21. Pisu MB, Guioli S, Conforti E, Bernocchi G. Signal molecules and receptors in the differential development of cerebellum lobules. Acute effects of cisplatin on nitric oxide and glutamate systems in Purkinje cell population. Brain Res Dev Brain Res. 2003;145(2):229-240. (Pubitemid 37357132)
22. Pisu MB, Roda E, Avella D, Bernocchi G. Developmental plasticity of rat cerebellar cortex after cisplatin injury: inhibitory synapses and differentiating Purkinje neurons. Neuroscience. 2004;129(3):655-664. (Pubitemid 39487118)
23. Avella D, Pisu MB, Roda E, Gravati M, Bernocchi G. Reorganization of the rat cerebellar cortex during postnatal development following cisplatin treatment. Exp Neurol. 2006;201(1):131-143. (Pubitemid 44223471)
24. Scherini E, Bernocchi G. CisDDP treatment and development of the rat cerebellum. Prog Neurobiol. 1994;42(2):161-196. (Pubitemid 24078967)
25. Malik NM, Moore GB, Smith G, Liu YL, Sanger GJ, Andrews PL. Behavioural and hypothalamic molecular effects of the anticancer agent cisplatin in the rat: a model of chemotherapyrelated malaise? Pharmacol Biochem Behav. 2006;83(1):9-20.
26. Zwelling L, Kohn K. Mechanism of action of cisdichlorodiammineplatinum (II). Cancer Treat Rep. 1979;63(9-10):1439-1444.
27. Wick A, Wick W, Hirrlinger J, Gerhardt E, Dringen R, Dichgans J, Weller M, Schulz JB. Chemotherapy induced cell death in primary cerebellar granule neurons but not in astrocytes: in vitro paradigm of differential neurotoxicity. J Neurochem. 2004;91(5):1067-1074. (Pubitemid 39587445)
28. Roda E, Avella D, Pisu MB, Bernocchi G. Monoamine receptors and immature cerebellum cytoarchitecture after cisplatin injury. J Chem Neuroanat. 2007;33(1):42-52. (Pubitemid 46177541)
29. Hajali V, Sheibani V, Esmaeili-Mahani S, Shabani M. Female rats aremore susceptible to the deleterious effects of paradoxical sleep deprivation on cognitive performance. Behav Brain Res. 2012;228(2):311-318.
30. Barnett RC, Biener LE, Baruch GK. Gender and stress. New York, NY: Free Press; 1987. xii 386 pp.
31. Allen JS, Damasio H, Grabowski TJ, Bruss J, Zhang W. Sexual dimorphism and asymmetries in the gray-white composition of the human cerebrum. Neuroimage. 2003;18(4):880-894. (Pubitemid 36513462)
32. Madeira MD, Lieberman, AR. Sexual dimorphism in the mammalian limbic system. Prog Neurobiol. 1995;45(4):275-333.
33. El-Shazly M, Afify M, El-Dieb M. Histopathological study into side-effect toxicity of some drugs used in treatment of cancer. Archiv fuer experimentelle Veterinaermedizin. 1989;43(2):319-326.
34. Sartelet H, Oligny LL, Vassal G. AKT pathway in neuroblastoma and its therapeutic implication. Expert Rev Anticancer Ther. 2008;8(5):757-769.
35. Troy L, McFarland K, Littman-Power S, Kelly BJ, Walpole ET, Wyld D, Thomson D. Cisplatin-based therapy: a neurological and neuropsychological review. Psychooncology. 2000;9(1):29-39. (Pubitemid 30110388)
36. Seigers R, Schagen SB, Beerling W, Boogerd W, van Tellingen O, van Dam FS, Koolhaas JM, Buwalda B. Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat. Behav Brain Res. 2008;186(2):168-175. (Pubitemid 350122748)
37. Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol. 2008;19(4):623-629. (Pubitemid 351461030)
38. Song TY, Chen CL, Liao JW, Ou HC, Tsai MS. Ergothioneine protects against neuronal injury induced by cisplatin both in vitro and in vivo. Food Chem Toxicol. 2010;48:3492-3499.
39. Joerg D, Dietrich J, Han R, Yang Y, Mayer-Pröschel M, Noble M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol 2006;5(7):22.
40. Bantel H, Engels IH, Voelter W, Schulze-Osthoff K, Wesselborg S. Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis. Cancer Res. 1999;59(9):2083-2090. (Pubitemid 29217669)
41. Kebieche M, Lakroun Z, Lahouel M, Bouayed J, Meraihi Z, Soulimani R. Evaluation of epirubicin-induced acute oxidative stress toxicity in rat liver cells and mitochondria, and the prevention of toxicity through quercetin administration. Exp Toxicol Pathol. 2009;61(2):161-167.
42. Geller HM, Cheng KY, Goldsmith NK, Romero AA, Zhang AL,Morris EJ, Grandison L.Oxidative stress mediates neuronal DNAdamage and apoptosis in response to cytosine arabinoside. J Neurochem. 2001;78(2):265-275. (Pubitemid 32664408)
43. Yang M, Kim JS, Song MS, Kim SH, Kang SS, Bae CS, Kim JC, Wang H, Shin T, Moon C. Cyclophosphamide impairs hippocampus-dependent learning and memory in adult mice: possible involvement of hippocampal neurogenesis in chemotherapy-induced memory deficits. Neurobiol Learn Mem. 2010;93(4):487-494.